Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
Autor: | Nobuaki Uchida, Miki Oono, Makoto Matsui, Megumi Nakanishi, Michiyo Fujita-Nakata, Ukichiro Kawai, Shigemi Nagayama, Mitsuru Sanada, Yoshimasa Fujita |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
Adult
Cellular immunity Prednisolone Immunology Anti-Inflammatory Agents Inflammation Case Report lcsh:RC346-429 Pathogenesis Arthritis Rheumatoid 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine Cerebrospinal fluid Antigens CD Myasthenia Gravis medicine Humans Meningitis Rheumatoid arthritis lcsh:Neurology. Diseases of the nervous system Rheumatoid meningitis 030203 arthritis & rheumatology business.industry Interleukin-6 General Neuroscience Aseptic meningitis medicine.disease Flow Cytometry Magnetic Resonance Imaging Myasthenia gravis Humoral immunity Treatment Outcome Neurology Female medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | Journal of Neuroinflammation Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-6 (2018) |
ISSN: | 1742-2094 |
Popis: | Background Rheumatoid meningitis (RM) is a rare disorder that often develops during a remission phase of rheumatoid arthritis (RA). This is the first study to demonstrate differences in regard to immunological disturbance between blood and cerebrospinal fluid (CSF) samples obtained from a patient with RM using flow cytometry. Case presentation A 36-year-old woman with RA and generalized myasthenia gravis (MG) developed RM during a remission phase. Although both RA and MG were stable and well controlled, she noticed fever, headache, and transient sensory disturbance. Blood and CSF examination findings suggested aseptic meningitis, while brain magnetic resonance imaging revealed restricted portions of meningitis and associated cortical lesions, compatible with a diagnosis of RM. The dose of oral prednisolone was increased, which ameliorated the symptoms within 1 week along with improvement in CSF findings. This patient exhibited features of RM that were manifested in a manner independent of the activity of RA. An investigation of cellular immunity using CSF specimens with flow cytometry showed differences in regard to the pathogenesis of inflammation in the CSF as compared to outside of the central nervous system. In contrast to results obtained with paired blood samples, CSF cells at the peak stage of RM showed a marked increase in CCR3+ Th2 cells and marked decrease in CD8+ cells, suggesting an immunoregulatory disturbance in the CSF. Those findings indicated a CSF-specific activation of humoral immunity, resulting in augmentation of meningeal inflammation, as shown by excess synthesis of intrathecal IgG and markedly elevated interleukin-6 level. Results of the present detailed investigation of lymphocyte subsets revealed a discrepancy regarding the process of inflammation in this RM patient between CSF and blood samples. Conclusions RM is not a simple reflection of the immune status of RA, as the pathogenesis seems related to, at least in part, CSF-specific immunological dysregulation. |
Databáze: | OpenAIRE |
Externí odkaz: |